Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Huddinge
Clinical trial register · Sweden

Clinical Trials in Huddinge, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2219 matching records held by the registry are in this view. Synced 12 Oct 2026, 03:19 UTC
2219
Studies in scope
all four open statuses
1247
Recruiting now
open to new participants
367
Lead sponsors
across recruiting studies
Top sites
Stockholm 930 Gothenburg 631 Lund 404 Uppsala 369 Linköping 236
Narrow the registerReset
Recruitment status
Phase
Site location
Stockholm930 Gothenburg631 Lund404 Uppsala369 Linköping236
All 146 locations
Target enrolment
to

Trials with a site in Huddinge

74 of 2219 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Not yet open
Sahlgrenska University Hospital
Phase 4
216
Malmö, Huddinge, Stockholm, Uppsala, Umeå, Sundsvall, Mölndal, Skövde
2027-01-11
Recruiting
Karolinska Institutet
Not applicable
30
Huddinge
2026-09-29
Not yet open
Efficacy of PRP Injections in Reducing Pain for Myogenous TMD Patients
NCT07606378Myogenic Temporomandibular Joint Disorders, Myofacial Pain, Masseter Muscle
Karolinska Institutet
Not applicable
50
Huddinge
2026-08-04
Recruiting
AstraZeneca
Phase 3
750
Gothenburg, Huddinge, Lund
2026-06-26
Recruiting
Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD
NCT07348783Cluster Headache - Episodic and Chronic, Migraine Headache, Migraine Headache, With or Without Aura, Migraine in Adults
Karolinska Institutet
Not applicable
80
Huddinge
2026-05-01
Recruiting
Unloaded Minds - How Prolonged Unloading Shapes Human Performance in Lunar Gravity
NCT07607340Unilateral Lower Limb Suspension (Simulated Microgravity)
Karolinska Institutet
Not applicable
24
Huddinge
2026-05-01
Recruiting
A Lifestyle Intervention to Reduce Cardiometabolic Risk Factors in Individuals With Obsessive-compulsive Disorder
NCT07206212Obsessive Compulsive Disorder (OCD), Lifestyle (Sedentary Behavior and Physical Activity)
Karolinska Institutet
Not applicable
108
Huddinge
2026-01-30
Recruiting
A Study of AZD0120 in Autoimmune Diseases
NCT07295847Systemic Sclerosis, Idiopathic Inflammatory Myopathies, Rheumatoid Arthritis
AstraZeneca
Phase 1
27
Huddinge
2026-01-09
Active, closed
Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD - a Pilot Study
NCT07292090Cluster Headache - Episodic and Chronic, Migraine Headache, Migraine Headache, With or Without Aura, Migraine in Adults
Karolinska Institutet
Not applicable
20
Huddinge
2026-01-01
Not yet open
Better4All Personalized Intervention
NCT06997510Obesity Prevention
Harokopio University
Not applicable
1,022
Huddinge
2025-10-01
Recruiting
Sanofi
Phase 3
124
Huddinge, Uppsala
2025-09-26
Recruiting
Movement Performance in Persons With Chronic Back Pain
NCT06891625Chronic Low-back Pain, Back Disorder
Karolinska Institutet
Not applicable
40
Huddinge
2025-09-01
Recruiting
Mirum Pharmaceuticals, Inc.
Phase 3
172
Huddinge
2025-08-27
Recruiting
Pfizer
Phase 3
300
Malmö, Huddinge
2025-07-14
Recruiting
eleva GmbH
Phase 1
39
Huddinge
2025-06-26
Recruiting
Karolinska University Hospital
Observational
100
Huddinge
2025-06-10
Recruiting
AstraZeneca
Phase 3
15,100
Alingsås, Falun, Huddinge, Lidköping, Lund, Östersund, Stockholm, Umeå
2025-06-04
Recruiting
Better4All Personalized Intervention Pilot Study
NCT07120802Obesity Prevention
Harokopio University
Not applicable
490
Huddinge
2025-06-01
Recruiting
Takeda
Phase 3
225
Örebro, Huddinge, Gothenburg, Lund
2025-05-06
Recruiting
TMJ Arthroscopy Compared to Arthrocentesis in Disc Displacement Without Reduction
NCT06782178Temporomandibular Joint Disc Displacement, Temporomandibular Joint Disc Displacement, Without Reduction, Temporomandibular Disorders (TMD)
Karolinska Institutet
Not applicable
100
Huddinge
2025-04-01
Recruiting
Karolinska Institutet
Not applicable
504
Huddinge
2025-04-01
Recruiting
TMJ Arthroscopic Lysis and Lavage Compared to Operative Arthroscopy in Disc Displacement With Reduction.
NCT06782191Temporomandibular Joint Disc Displacement, With Reduction, Temporomandibular Disorders (TMD)
Karolinska Institutet
Not applicable
96
Huddinge
2025-04-01
Recruiting
Long-term Follow up of TMJ Surgery and Evaluation of the 6-month Control as a Prognostic Marker.
NCT06782165Temporomandibular Disorders (TMD), Temporomandibular Joint Disc Displacement, With Reduction, Temporomandibular Joint Disc Displacement, Without Reduction
Karolinska Institutet
Observational
91
Huddinge
2025-04-01
Recruiting
AstraZeneca
Phase 3
11,300
Gothenburg, Helsingborg, Huddinge, Lund, Mölndal, Norrköping, Stockholm, Uppsala
2025-03-14
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
440
Gothenburg, Huddinge, Lund
2025-03-12
Recruiting
AstraZeneca
Phase 3
5,000
Huddinge, Karlstad, Linköping, Stockholm, Uppsala, Vaxjo
2025-03-03
Recruiting
Takeda
Phase 3
171
Huddinge, Malmö
2025-02-27
Recruiting
Cognitive Impact Associated With Surgery For Gastric Or Esophageal Cancer
NCT06687291Gastroesophageal Cancer (GC), Postoperative Delirium (POD), Quality of Life (QOL), Frailty
Karolinska Institutet
Observational
130
Huddinge
2025-02-13
Recruiting
Aileen Bergström
Not applicable
100
Huddinge, Uppsala
2025-02-03
Recruiting
The Effect of the Nutraceutical (-)- Epicatechin on Myosteatosis in Patients With Advanced CKD
NCT06631820Chronic Kidney Disease(CKD), Myosteatosis, Mitochondrial Dysfunction, Muscle Function
Karolinska Institutet
Not applicable
10
Huddinge
2025-01-17
Recruiting
Dysfunctional Breathing in Post COVID-19 Condition.
NCT06776263Post COVID-19 Condition (PCC), Dysfunctional Breathing, Breathing Pattern Disorder, Post-Acute COVID-19 Syndrome
Karolinska Institutet
Observational
200
Stockholm, Huddinge
2025-01-15
Recruiting
International Care Bundle Evaluation in Cerebral Hemorrhage Research
NCT06429332Intracerebral Hemorrhage, Intracerebral Haemorrhage, Intraventricular Hemorrhage, Stroke
Region Skane
Phase 4
3,500
Eksjö, Gothenburg, Hässleholm, Helsingborg, Huddinge, Jönköping, Kalmar, Karlskrona
2025-01-07
Active, closed
AbbVie
Observational
1,314
Huddinge, Stockholm, Lund
2024-11-26
Recruiting
Stroke Alarm Efficacy Trial
NCT06315192Stroke Acute, Atrial Fibrillation, TIA
Region Skane
Not applicable
500
Gothenburg, Hässleholm, Helsingborg, Huddinge, Linköping, Lund, Malmö, Stockholm
2024-09-05
Active, closed
Alpine Immune Sciences Inc, A Subsidiary of Vertex
Phase 3
605
Danderyd, Gothenburg, Huddinge, Linköping, Uppsala
2024-08-30
Recruiting
First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
NCT06351592Amyotrophic Lateral Sclerosis (ALS), Mutation in the Superoxide Dismutase-1 (SOD1) Gene
Regeneron Pharmaceuticals
Phase 1/2
54
Umeå, Huddinge
2024-08-28
Recruiting
Jazz Pharmaceuticals
Phase 3
286
Gothenburg, Huddinge, Malmö
2024-07-19
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Lund, Huddinge, Uppsala, Gothenburg, Örebro
2024-07-16
Recruiting
CSL Behring
Phase 2/3
3,110
Huddinge, Stockholm, Uppsala
2024-04-27
Active, closed
Sanofi
Phase 3
943
Gothenburg, Huddinge, Malmö, Stockholm
2023-12-27
Active, closed
argenx
Observational
413
Gothenburg, Huddinge
2023-11-29
Recruiting
Can the Use of a Next Generation Partograph Improve Neonatal Outcomes? (PICRINO)
NCT05560802Neonatal Complication, Labor (Obstetrics)--Complications
Linkoeping University
Not applicable
120,000
Eksjö, Falun, Gällivare, Gothenburg, Helsingborg, Huddinge, Hudiksvall, Jönköping
2023-11-15
Recruiting
Karolinska Institutet
Phase 2
100
Huddinge
2023-11-14
Recruiting
Claus Lindbjerg Andersen
Observational
590
Huddinge
2023-08-01
Active, closed
Hansa Biopharma AB
Phase 3
150
Huddinge, Uppsala
2023-07-03
Recruiting
Population Health Research Institute
Not applicable
5,100
Huddinge, Jönköping, Karlstad, Lund, Stockholm, Umeå, Uppsala
2023-06-22
Recruiting
Imlifidase Prior to Kidney Transplant in Highly Sensitised Children
NCT05753930Kidney Transplantation in Highly Sensitized Patients
Hansa Biopharma AB
Phase 2
10
Huddinge
2023-06-02
Active, closed
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
NCT05705973Cardiovascular Disease, Coronary Artery Occlusion, Ischemic Heart Disease
Terumo Europe N.V.
Observational
3,000
Gävle, Huddinge
2023-04-25
Active, closed
Large Scale Implementation of MINISTOP 3.0
NCT05667753Obesity, Child
Karolinska Institutet
Not applicable
120
Huddinge
2023-03-13
By invitation
Single Nuclei Sequencing in Human Skeletal Muscle After Unloading
NCT05801185Unilateral Lower Limb Suspension
Karolinska Institutet
Not applicable
20
Huddinge
2023-03-05
Recruiting
AstraZeneca
Phase 3
3,527
Helsingborg, Huddinge, Lund, Malmö, Solna, Stockholm, Umeå, Västerås
2022-12-13
Recruiting
Immune Cells in Diabetic Chronic Foot Ulcers
NCT06154915Diabetic Foot, Immune Defect
Karolinska Institutet
Observational
40
Huddinge
2022-09-09
Recruiting
Factors for the Onset and Course of Axial Spondylitis
NCT06594107Axial Spondyloarthritis
Karolinska Institutet
Observational
1,000
Huddinge, Stockholm
2022-09-01
Active, closed
Sanofi
Phase 3
531
Borås, Huddinge
2022-06-23
Active, closed
Sanofi
Phase 2
48
Huddinge, Uppsala
2022-06-09
Recruiting
Investigating Neural Response Variability as a Single-patient Predictor of Successful CBT in Clinical Psychiatry
NCT04191811Psychiatric Disorder, Depression, Anxiety Disorders, Insomnia
Karolinska Institutet
Observational
150
Huddinge
2022-04-01
Active, closed
UCB Biopharma SRL
Phase 3
113
Huddinge
2022-02-02
Recruiting
medac GmbH
Phase 3
210
Huddinge
2021-08-16
Recruiting
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia
NCT04598750Neonatal Thrombocytopenia, Bleeding
Karolinska Institutet
Observational
250
Huddinge, Stockholm
2021-06-15
Active, closed
Onset PrevenTIon of Urinary Retention in Orthopaedic Nursing and Rehabilitation
NCT04700969Urinary Retention, Hip Fractures, Hip Arthritis
Örebro University, Sweden
Not applicable
20
Arvika, Danderyd, Eksjö, Enköping, Eskilstuna, Huddinge, Johanneshov, Karlskoga
2020-12-15
Recruiting
Thomas Helleday Foundation
Phase 1
50
Huddinge, Örebro
2019-12-03
Active, closed
Overweight and Obesity in Preschoolers
NCT03800823Obesity, Overweight
Karolinska Institutet
Not applicable
300
Huddinge
2019-02-15
Recruiting
Uppsala University
Phase 3
2,000
Angered, Ängelholm, Falun, Finspång, Flen, Gothenburg, Hemse, Huddinge
2017-11-23
Active, closed
Aarhus University Hospital Skejby
Not applicable
1,201
Huddinge, Gothenburg, Örebro, Stockholm
2017-07-05
Active, closed
Oslo University Hospital
Phase 2/3
140
Gothenburg, Huddinge, Linköping, Lund, Umeå, Uppsala
2016-09
Recruiting
The European NAFLD Registry
NCT04442334NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Fibrosis, Liver
Newcastle University
Observational
10,000
Huddinge, Linköping
2015-05-01
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
Novartis Pharmaceuticals
Phase 4
279
Huddinge, Luleå, Lund, Uddevalla
2015-03-05
Rows per page Showing 1–74 of 74
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-sweden/city/huddinge

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,219 studies in total at the last sync on 12 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 74 of those studies with a site in Huddinge.

How many clinical trials are recruiting in Huddinge?

51 of the 74 studies on this page are recruiting new participants as of the 12 Oct 2026, 03:19 UTC sync. A further 3 have not yet opened recruitment, 19 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Huddinge), 74 studies
PhaseStudiesRecruitingShare
Phase 3271936.5%
Not applicable221429.7%
Observational131017.6%
Phase 1334.1%
Phase 2324.1%
Phase 4314.1%
Phase 2/3212.7%
Phase 1/2111.4%

Most active sponsors

Lead sponsors with the most studies (Huddinge)
Lead sponsorStudiesRecruiting
Karolinska Institutet2217
AstraZeneca66
Sanofi62
Takeda44
Hansa Biopharma AB21
Harokopio University21
Merck Sharp & Dohme LLC20
Region Skane22
Aarhus University Hospital Skejby10
AbbVie10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.